These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 28576117

  • 1. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis.
    Eljaaly K, Alshehri S, Aljabri A, Abraham I, Al Mohajer M, Kalil AC, Nix DE.
    BMC Infect Dis; 2017 Jun 02; 17(1):385. PubMed ID: 28576117
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
    Raz-Pasteur A, Shasha D, Paul M.
    Int J Antimicrob Agents; 2015 Sep 02; 46(3):242-8. PubMed ID: 26092096
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of empiric macrolides versus fluoroquinolones in community-acquired pneumonia associated with atypical bacteria: A meta-analysis.
    Basilim A, Wali H, Rabaan AA, Eljaaly K.
    Respir Med Res; 2022 Nov 02; 82():100931. PubMed ID: 35905552
    [Abstract] [Full Text] [Related]

  • 6. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.
    Shefet D, Robenshtock E, Paul M, Leibovici L.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD004418. PubMed ID: 15846713
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Empiric Antibiotic Treatment Regimens for Hospitalized, Non-severe Community-acquired Pneumonia: A Retrospective, Multicenter Cohort Study.
    Reeves SD, Hartmann AP, Tedder AC, Juang PA, Hofer M, Kollef MH, Micek ST, Betthauser KD.
    Clin Ther; 2024 Apr 18; 46(4):338-344. PubMed ID: 38403509
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
    Vardakas KZ, Trigkidis KK, Falagas ME.
    Clin Microbiol Infect; 2017 Apr 18; 23(4):234-241. PubMed ID: 27965070
    [Abstract] [Full Text] [Related]

  • 11. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.
    Choi SH, Cesar A, Snow TAC, Saleem N, Arulkumaran N, Singer M.
    Int J Antimicrob Agents; 2023 Sep 18; 62(3):106905. PubMed ID: 37385561
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
    Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM.
    BMC Infect Dis; 2019 Jan 07; 19(1):17. PubMed ID: 30612559
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibiotic treatment outcomes in community-acquired pneumonia.
    Çilli A, Sayıner A, Çelenk B, Şakar Coşkun A, Kılınç O, Hazar A, Aktaş Samur A, Taşbakan S, Waterer GW, Havlucu Y, Kılıç Ö, Tokgöz F, Bilge U.
    Turk J Med Sci; 2018 Aug 16; 48(4):730-736. PubMed ID: 30119147
    [Abstract] [Full Text] [Related]

  • 17. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
    Gilbert TT, Arfstrom RJ, Mihalovic SW, Dababneh AS, Varatharaj Palraj BR, Dierkhising RA, Mara KC, Lessard SR.
    Am J Ther; 2020 Aug 16; 27(2):e177-e182. PubMed ID: 30418221
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM, Restrepo MI, Anzueto A, Pugh J.
    Crit Care; 2005 Dec 06; 10(1):R8. PubMed ID: 16420641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.